<![CDATA[Fixed-Duration Bispecific Therapy for Deep, Sustained Responses in Multiple Myeloma]]>

Bispecific TherapyPositive

AI Analysis

Summary

Dr. Ralph V. Boccia discussed the therapeutic potential of fixed-duration bispecific therapy in multiple myeloma patients achieving deep, sustained responses. The discussion highlights a shift toward limiting treatment duration for eligible patients.

Importance:3/10

Sentiment:

0.50

Multiple MyelomaBispecific TherapyFixed-Duration TreatmentDeep Response

Read the original article

Published by Cancer Network on October 14, 2026 6:00 PM

Read Original